middle.news
Proteomics International Advances Commercial Pivot with Healius Deal and US Patent
9:48am on Monday 27th of July, 2026 AEST
•
Healthcare
Read Story
Proteomics International Advances Commercial Pivot with Healius Deal and US Patent
9:48am on Monday 27th of July, 2026 AEST
Key Points
25% staff reduction to cut costs and sharpen commercial focus
Exclusive three-year distribution agreement signed with Healius
US patent granted for PromarkerEndo endometriosis diagnostic
Cash burn of $2.08 million includes $0.46 million redundancy costs
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE